Clinical Trial Update: Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A [Phase 3]

View source ↗

Summary

Phase III expansion trial evaluating the safety and efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for injection in adolescents and adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• recombinant human coagulation factor VIII-Fc fusion protein (factor VIII-Fc fusion protein)

Snippet

Sponsor: Zhengzhou Gensciences Inc | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED